ACTG Publications

Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development.Morris, Bethany L ; Scott, Callie A ; Wilkin, Timothy J ; Sax, Paul E ; Gulick, Roy M ; Freedberg, Kenneth A ; Schackman, Bruce R2012 Jan-FebHIV Clin Trials113
Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial.Schackman, Bruce R ; Scott, Callie A ; Sax, Paul E ; Losina, Elena ; Wilkin, Timothy J ; McKinnon, John E ; Swindells, Susan ; Weinstein, Milton C ; Freedberg, Kenneth A2007 Oct 15Clin Infect Dis845